Common IL-31 gene haplotype associated with non-atopic eczema is not implicated in epidermolysis bullosa pruriginosa

Acta Dermato-Venereologica

Volumn 90, Issue 6, 2010, Pages 631-632

  Nagy, Nikoletta ^a   Tanaka, Akio ^a   Techanukul, Tanasit ^a   McGrath, John A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; FILAGGRIN; IMMUNOGLOBULIN E; INTERLEUKIN 31; INTERSTITIAL COLLAGENASE;

ATOPIC DERMATITIS; ATOPY; BIOCHEMISTRY; BLISTER; CONTROLLED STUDY; DNA POLYMORPHISM; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA PRURIGINOSA; GENE MUTATION; HAPLOTYPE; HUMAN; IRON DEFICIENCY; LETTER; LICHEN PLANUS; MOUSE; NAIL DYSTROPHY; NEURODERMATITIS; NON ATOPIC ECZEMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PRURIGO; PRURITUS; SCRATCHING;

CASE-CONTROL STUDIES; ECZEMA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKINS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 78649713165     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0958     Document Type: Letter

References (15)

1. McGrath JA, Schofield OM, Eady RA. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol 1994; 130: 617-625.
2. Fine JD, Eady RA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, et al. The classification of inherited epidermolysis bullosa: report of the third international consensus meeting on the diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2008; 58: 931-950.
3. Mellerio JE, Ashton GH, Mohammedi R, Lyon CC, Kirby B, Harman KE, et al. Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol 1999; 112: 984-987.
4. Almaani N, Liu L, Harrison N, Tanaka A, Lai-Cheong J, Mellerio JE, et al. New glycine substitution mutations in type VII collagen underlying epidermolysis bullosa pruriginosa but the phenotype is not explained by a common polymorphism in the matrix metalloproteinase-1 gene promoter. Acta Derm Venereol 2009; 89: 6-11.
5. Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 2008; 17: 553-568.
6. Schumann H, Has C, Kohlhase J, Bruckner-Tuderman L. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations. Br J Dermatol 2008; 159: 464-469.
7. Greaves MW. Pathogenesis and treatment of pruritus. Curr Allergy Asthma Rep 2010; 10: 236-242.
8. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760.
9. Raap U, Wichmann K, Bruder M, Ständer S, Wedi B, Kapp A, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008; 122: 421-423.
10. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006; 118: 930-937.
11. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006; 117: 411-417.
12. Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W. Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 2008; 19: 347-356.
13. Tanaka A, Lai-Cheong JE, van den Akker PC, Nagy N, Millington G, Diercks GF, et al. The molecular skin pathology of familial primary localized cutaneous amyloidosis. Exp Dermatol 2010; 19: 416-423.
14. Schulz F, Marenholz I, Fölster-Holst R, Chen C, Sternjak A, Baumgrass R, et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol 2007; 120: 1097-1102.
15. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Grønhøj-Larsen C, et al. Anti-interleukin-31- antibodies ameliorate scratching behaviour in NC/NgA mice: a model of atopic dermatitis. Exp Dermatol 2009; 18: 35-43.